Q32 Bio Inc (NASDAQ:QTTB) currently has a daily average trading volume of 1.29M but it saw 1525843 shares traded in last market. With a market cap of 28.30M USD, the company’s current market price of $2.32 came falling about -16.55 while comparing to the previous closing price of $2.78. In past 52 weeks, the stock remained buoying in the range of price level as high as $53.79 and as low as $1.35. In the recent trading on the day, stock has struck highest price mark of $2.26 while lowest mark touched by it was $2.8.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Piper Sandler which downgraded the stock as “Neutral” in its note to investors issued on February 11, 2025, recommending a price target of between $20 and $4 for it. BMO Capital Markets downgraded its recommendation for the stock as a “Market Perform” from “Outperform” on February 11, 2025 while assigning a price target range of $22-$3. Wells Fargo also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $95 and $16.
Over the week, QTTB’s stock price is moving -30.12% down while it is 38.10% when we observe its performance for the past one month. Year-to-date it is -91.00% down and over the past year, the stock is showing a downside performance of -32.56%.
The company is expected to be releasing its next quarterly report on 2025-May-08, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Q32 Bio Inc’s total number of outstanding shares is 12.20M. Company’s return on investment (ROI) stands at -629.93% and return on equity (ROE) at -267.20%. Stock’s beta reads -0.05. Its return on asset (ROA) is -51.68% on average.
